Christoph Lacroix: “Bifidobacteria are critical for microbiota development in infants”

Staff editor

26.01.2023

According to Christoph Lacroix (ETH Zurich), bifidobacteria are critical in the development of the neonatal microbiota. Here's why.

According to Christoph Lacroix (ETH Zurich), bifidobacteria are critical in the development of the neonatal microbiota. Here’s why.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Christoph Lacroix: “Bifidobacteria are critical for microbiota development in infants”

Latest related content

Gut bacteria and diet boost immune response against brain cancer in mice

Insights into Indigenous skin microbiotas offer clues to fungal infection

The microbiome and athletic performance: scientific insights and investment landscape

Engineering the gut: Endure Biotherapeutics secures NIH funding for groundbreaking FAP therapy

Mice study shows how gut bacteria help train immune cells to prevent inflammation

A $2.5 billion catalyst: how the Gates Foundation is redefining women’s health innovation—with the microbiome in the spotlight

Latest News